Takeda expands gastroenterology efforts: Announces collaboration with NuBiyota: 3 insights

Listen
Text
  • Small
  • Medium
  • Large

Osaka, Japan-based Takeda Pharmaceuticals entered into a strategic collaboration with Teaneck, N.J.-based NuBiyota for its microbial ecosystem therapeutic products.

Here's what you should know.

1. Takeda and NuBiyota are collaborating on oral microbial consortia products, which NuBiyota will develop.

2. Takeda will pay NuBiyota an upfront payment as well as several developmental, regulatory, commercial and sales-based incentives.

3. Takeda recently entered into a similar agreement with Finch Therapeutics over its inflammatory bowel disease treatment.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast